Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (41-50 of 902) with videos related to

Pageof 91
Sort By:
Current Treatment Options in Oncology|April 30, 2004
Treatment of POEMS syndromeAngela Dispenzieri, Morie A Gertz
Expert Opinion on Pharmacotherapy|June 15, 2005
Treatment options for POEMS syndromeAngela Dispenzieri, Morie A Gertz
Haematologica|October 13, 2005
Evaluation and monitoring of response to therapy in multiple myelomaS Vincent Rajkumar, Angela Dispenzieri
Best Practice & Research. Clinical Haematology|July 20, 2005
Neurological aspects of multiple myeloma and related disordersAngela Dispenzieri, Robert A Kyle
Clinical Chemistry|October 30, 2008
Screening algorithms for monoclonal gammopathiesJerry A Katzmann, Angela Dispenzieri
Oncology (Williston Park, N.Y.)|April 12, 2012
Immunoglobulin light-chain amyloidosis: growing recognition, new approaches to therapy, active clinical trialsMorie A Gertz, Angela Dispenzieri
Expert Review of Clinical Immunology|December 18, 2010
Serum free light chain analysis in multiple myeloma and plasma cell dyscrasiasGuner Hayri Ozsan, Angela Dispenzieri
Oncology (Williston Park, N.Y.)|March 15, 2014
A review of POEMS syndromeAngela Dispenzieri, Francis K Buadi
Current Treatment Options in Oncology|May 5, 2005
Treatment of Castleman's diseaseAngela Dispenzieri, Morie A Gertz
Best Practice & Research. Clinical Haematology|July 20, 2005
Multiple myeloma: clinical features and indications for therapyAngela Dispenzieri, Robert A Kyle
Pageof 91

Showing results (41-50 of 902) with videos related to

Sort By:
Pageof 91
Current Treatment Options in Oncology|April 30, 2004
Treatment of POEMS syndromeAngela Dispenzieri, Morie A Gertz
Expert Opinion on Pharmacotherapy|June 15, 2005
Treatment options for POEMS syndromeAngela Dispenzieri, Morie A Gertz
Haematologica|October 13, 2005
Evaluation and monitoring of response to therapy in multiple myelomaS Vincent Rajkumar, Angela Dispenzieri
Best Practice & Research. Clinical Haematology|July 20, 2005
Neurological aspects of multiple myeloma and related disordersAngela Dispenzieri, Robert A Kyle
Clinical Chemistry|October 30, 2008
Screening algorithms for monoclonal gammopathiesJerry A Katzmann, Angela Dispenzieri
Oncology (Williston Park, N.Y.)|April 12, 2012
Immunoglobulin light-chain amyloidosis: growing recognition, new approaches to therapy, active clinical trialsMorie A Gertz, Angela Dispenzieri
Expert Review of Clinical Immunology|December 18, 2010
Serum free light chain analysis in multiple myeloma and plasma cell dyscrasiasGuner Hayri Ozsan, Angela Dispenzieri
Oncology (Williston Park, N.Y.)|March 15, 2014
A review of POEMS syndromeAngela Dispenzieri, Francis K Buadi
Current Treatment Options in Oncology|May 5, 2005
Treatment of Castleman's diseaseAngela Dispenzieri, Morie A Gertz
Best Practice & Research. Clinical Haematology|July 20, 2005
Multiple myeloma: clinical features and indications for therapyAngela Dispenzieri, Robert A Kyle
Pageof 91